RiverFront Investment Group LLC Has $952,000 Stock Holdings in Corteva, Inc. (NYSE:CTVA)

RiverFront Investment Group LLC increased its position in shares of Corteva, Inc. (NYSE:CTVA) by 43.7% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 16,721 shares of the company’s stock after purchasing an additional 5,081 shares during the quarter. RiverFront Investment Group LLC’s holdings in Corteva were worth $952,000 at the end of the most recent quarter.

A number of other institutional investors also recently modified their holdings of the company. Flagship Wealth Advisors LLC acquired a new position in Corteva in the fourth quarter worth $25,000. Noble Wealth Management PBC acquired a new position in Corteva during the 4th quarter worth about $26,000. Hager Investment Management Services LLC bought a new stake in Corteva during the 4th quarter worth about $27,000. Golden State Wealth Management LLC acquired a new stake in Corteva in the 4th quarter valued at about $32,000. Finally, Centricity Wealth Management LLC bought a new position in shares of Corteva in the fourth quarter worth about $34,000. Institutional investors own 81.54% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages recently weighed in on CTVA. The Goldman Sachs Group began coverage on shares of Corteva in a report on Thursday, March 13th. They issued a “buy” rating and a $71.00 price target for the company. Oppenheimer boosted their target price on Corteva from $70.00 to $72.00 and gave the stock an “outperform” rating in a research report on Friday, February 7th. UBS Group decreased their price target on Corteva from $74.00 to $73.00 and set a “buy” rating on the stock in a report on Friday, January 10th. KeyCorp boosted their price objective on Corteva from $68.00 to $70.00 and gave the stock an “overweight” rating in a report on Friday, February 7th. Finally, Wells Fargo & Company raised their price objective on shares of Corteva from $67.00 to $73.00 and gave the company an “overweight” rating in a research note on Tuesday, January 28th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and thirteen have issued a buy rating to the stock. According to MarketBeat, Corteva presently has an average rating of “Moderate Buy” and an average price target of $68.00.

Corteva Price Performance

Shares of NYSE CTVA opened at $61.08 on Friday. Corteva, Inc. has a fifty-two week low of $50.01 and a fifty-two week high of $66.24. The business has a fifty day moving average price of $62.53 and a two-hundred day moving average price of $60.07. The company has a debt-to-equity ratio of 0.08, a current ratio of 1.45 and a quick ratio of 0.93. The stock has a market capitalization of $41.72 billion, a PE ratio of 47.35, a P/E/G ratio of 1.68 and a beta of 0.79.

Corteva (NYSE:CTVA) last announced its quarterly earnings results on Wednesday, February 5th. The company reported $0.32 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.34 by ($0.02). Corteva had a net margin of 5.36% and a return on equity of 7.19%. As a group, equities analysts predict that Corteva, Inc. will post 2.96 earnings per share for the current fiscal year.

Corteva Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, March 17th. Stockholders of record on Monday, March 3rd were paid a $0.17 dividend. The ex-dividend date was Monday, March 3rd. This represents a $0.68 annualized dividend and a dividend yield of 1.11%. Corteva’s payout ratio is 52.71%.

Insider Activity

In other news, insider Brian Titus sold 26,560 shares of the company’s stock in a transaction on Thursday, February 20th. The shares were sold at an average price of $63.74, for a total value of $1,692,934.40. Following the completion of the sale, the insider now owns 11,347 shares in the company, valued at $723,257.78. This represents a 70.07 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. 0.14% of the stock is currently owned by company insiders.

About Corteva

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.